Intestinal IL-22 enhanced GLP-1 production via the STAT3 signaling pathway, improving glucose metabolism and providing a mechanistic link between gut immune signaling and incretin hormone secretion.
Immune system boosts GLP-1The gut immune molecule IL-22 directly stimulates cells to produce more GLP-1 — connecting immune health to blood sugar control at the molecular level
What the researchers found
Intestinal IL-22 enhances L-cell GLP-1 production via STAT3 pathway, improving glucose metabolism and mechanistically linking gut immunity to incretin hormone secretion.
Why it matters
Understanding how gut immunity boosts natural GLP-1 could lead to immune-based strategies for improving diabetes without drugs.
How the study worked
Study of IL-22 effects on intestinal L-cell GLP-1 secretion, STAT3 pathway characterization, and glucose metabolism assessment.
What this study cannot tell us
Mechanistic study. Cannot determine clinical significance of immune-mediated GLP-1 changes.
How to read the evidence
Mechanistic study establishing the IL-22/STAT3/GLP-1 pathway.
When this study was published
Published in 2025.
The bigger picture
The gut immune-incretin axis connects immune health to metabolic health at the molecular level — inflammation in the gut literally affects blood sugar.
Questions still open
- Could IL-22-based therapies boost GLP-1 enough to treat diabetes?
- Does gut inflammation reduce GLP-1 through IL-22 suppression?
- Would probiotics that increase IL-22 also boost GLP-1?
Common questions
How does gut health affect blood sugar?
Could improving gut immunity help diabetes?
Read the original research
Intestinal interleukin-22 enhances GLP-1 production via the STAT3 pathway to improve glucose homeostasis during high-fat diet induced obesity in a study with male mice.
Nature communications
Citation
Kim, Chae-Won; Ahn, Jae-Hee; Lee, Bo Ra; Kim, Hong Min; Han, Youngjoo; Jeong, Jae-Hyeon; Cho, Jaewon; Jeong, Hyunjin; Kim, Dae-Joon; Kim, Seong-Eun; Kim, Jeon-Kyung; Lee, Yu-Bin; Kim, Su Min; Yoo, Hye Hyun; Lee, Eun Hye; Seo, Su Ryeon; Ha, Kyung Bong; Lee, Eun Soo; Kweon, Mi-Na; Kim, Hong Pyo; Chang, Sun-Young; Chung, Choon Hee; Ko, Hyun-Jeong. (2026). Intestinal interleukin-22 enhances GLP-1 production via the STAT3 pathway to improve glucose homeostasis during high-fat diet induced obesity in a study with male mice.. Nature communications. https://doi.org/10.1038/s41467-026-69734-0